Abstract
1. To determine biological functions of platelet-activating factor (PAF) in chronic inflammation, we have investigated the kinetics of angiogenesis, inflammatory cells recruitment and cytokine production in sponge-induced granuloma in wild type and PAF receptor-deficient mice (PAFR-KO). 2. Angiogenesis as determined by morphometric analysis and hemoglobin content was significantly higher in the implants of PAFR-KO mice at all time points. Treatment with PAF receptor antagonist UK74505 (30 mg kg(-1)) also increased angiogenesis in sponge implants. 3. Neutrophils and macrophages accumulation, as determined by myeloperoxidase and N-acetylglucosaminidase activities in the supernatant of implanted sponges were markedly decreased in PAFR-KO mice. Surprisingly, the levels of the proinflammatory chemokines, keratinocyte-derived chemokine and chemokine monocyte chemoattractant protein 1 were higher in the implants of the transgenic animals. 4. We have shown that angiogenesis was stimulated in PAFR-KO mice whereas inflammation was decreased, indicating that PAF is an endogenous regulator of new blood vessels formation in the inflammatory microenvironment induced by the sponge implant.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acetylglucosaminidase
-
Administration, Topical
-
Animals
-
Blood Vessels / growth & development
-
Blood Vessels / pathology
-
Chemokines / metabolism
-
Dihydropyridines / adverse effects
-
Dihydropyridines / therapeutic use
-
Fibroblasts / pathology
-
Granulation Tissue / physiopathology
-
Granuloma / chemically induced
-
Granuloma / pathology
-
Hemoglobins / chemistry
-
Imidazoles / adverse effects
-
Imidazoles / therapeutic use
-
Implants, Experimental / adverse effects
-
Inflammation / chemically induced
-
Inflammation / physiopathology
-
Inflammation / prevention & control
-
Macrophages / pathology
-
Mice
-
Mice, Inbred BALB C
-
Mice, Knockout
-
Neovascularization, Pathologic / chemically induced*
-
Neovascularization, Pathologic / physiopathology
-
Neovascularization, Pathologic / prevention & control
-
Neutrophils / pathology
-
Peroxidase
-
Platelet Activating Factor / administration & dosage
-
Platelet Activating Factor / metabolism
-
Platelet Activating Factor / pharmacokinetics
-
Platelet Membrane Glycoproteins / antagonists & inhibitors
-
Platelet Membrane Glycoproteins / deficiency*
-
Platelet Membrane Glycoproteins / genetics*
-
Polyurethanes / administration & dosage
-
Polyurethanes / adverse effects*
-
Polyurethanes / chemistry*
-
Porifera / chemistry*
-
Receptors, G-Protein-Coupled / antagonists & inhibitors
-
Receptors, G-Protein-Coupled / deficiency*
-
Receptors, G-Protein-Coupled / genetics*
-
Skin / blood supply
-
Skin / pathology
Substances
-
Chemokines
-
Dihydropyridines
-
Hemoglobins
-
Imidazoles
-
Platelet Activating Factor
-
Platelet Membrane Glycoproteins
-
Polyurethanes
-
Receptors, G-Protein-Coupled
-
platelet activating factor receptor
-
polyetherurethane
-
modipafant
-
Peroxidase
-
Acetylglucosaminidase